MRK - Merck Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Company Name or Ticker Symbol

Search for other Categories

Merck & Co., Inc. (MRK)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Price: $74.7800 $-1.57

-2.056%

Day's High:	$ 76.36	Week Perf:	0.93 %
Day's Low:	$ 74.65	30 Day Perf:	3.05 %
Volume (M):	13,588	52 Wk High:	$ 76.61
Volume (M$):	$ 1,016,126	52 Wk Avg:	$ 62.06
Open:	$ 76.01	52 Wk Low:	$ 52.83

MRK Charts & Quotes

You need to upgrade your Flash Player

Description of Company's Segments

Market Capitalization (Millions $)	199,755
Shares Outstanding (Millions)	2,671
Employees	70,000
Revenues (TTM) (Millions $)	41,729
Net Income (TTM) (Millions $)	3,377
Cash Flow (TTM) (Millions $)	-1,809
Capital Exp. (TTM) (Millions $)	2,401

Merck & Co., Inc.
Merck & Co., Inc., is a global research-driven pharmaceutical products company that discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. The Company sells its products primarily to drug wholesalers and retailers, hospitals, clinics, government agencies and managed health care providers such as health maintenance organizations and other institutions. The Company’s professional representatives communicate the effectiveness, safety and value of its products to health care professionals in private practice, group practices and managed care organizations.

MRK is expected to report next financial results on January 28, 2019.

Next quarterly dividend payout on January 07, 2019.

Merck's Segments


Zocor	Segment	0.57 %	of total Revenue
Zetia	Segment	6.48 %	of total Revenue
CozaarHyzaar	Segment	1.54 %	of total Revenue
Singulair	Segment	2.06 %	of total Revenue
Proscar	Segment	0.42 %	of total Revenue
Isentress	Segment	3.86 %	of total Revenue
Primaxin	Segment	0.77 %	of total Revenue
Remicade	Segment	4.52 %	of total Revenue
Januvia	Segment	10.38 %	of total Revenue
Cancidas	Segment	1.42 %	of total Revenue
Other	Segment	59.33 %	of total Revenue
Merck Pharmaceutical	Segment	91.34 %	of total Revenue
Vaccines	Segment	11.28 %	of total Revenue
All Other	Segment	8.66 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Merck announced annual revenue outlook on Jul. 28, 2015 • Earnings Outlook Merck & Co., Inc. issued annual earnings guidance on Jul. 28, 2015

Geographic Revenue Dispersion
United States	40.42 %
EMEA	31.19 %
Japan	8.22 %
Other	3.36 %
Asia Pacific	9.35 %
Latin America	7.46 %

News

Ideanomics, Inc.

Ideanomics, Inc announced third quarter operating loss of $-6.356557 millions

Company losses widen at $-0.10 per share in the third quarter, although it's Sales surged by 44.62 % to $43.71 millions from the same quarter a year ago.

Apollo Medical Holdings, Inc.

Apollo Medical Holdings, Inc announced third quarter operating profit of $56.577104 millions

Despite very strong Sales growth of 313.21 % year on year to $167.28 millions in the third quarter, company faced earnings turn positive at $0.24.

Cell Source, Inc.

Redemption of Losses but Revenues Unchanged

In the third quarter Cell Source, Inc decreased loss of $-0.01 per share compare to $-0.03 a year ago and improved from $-0.02 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Rokk3r Inc.

Rokk3r Inc announced third quarter operating deficit of $-0.945653 millions

In the third quarter Rokk3r Inc lost money of $-0.01 per share compare to $-0.11 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.58 millions from $0.00 millions in the same quarter a year ago and sequentially Sales improved by 15.06 % from $0.51 millions.

Str Holdings, Inc.

Deficit Bigger Than a Year Ago, Sales Faded

Weak demand caused increase in losses for the third quarter, company's loss per share grew to $-0.07 from $-0.05 where Sales fell by -27.91 % to $2.55 millions from $3.53 millions a year ago.

MRK's Valuation	Current
Price to Earnings PE Ratio (TTM)	60.22
Price to Earnings PE Ratio (Expected)	46.30
Price to Sales (TTM)	4.79
Price to Sales (Expected)	5.12
Price to Book	6.12
PEG (TTM)	3.06

MRK's Financial Strength	Current
Quick Ratio	0.55
Working Capital Ratio	1.44
Leverage Ratio (MRQ)	1.55
Total Debt to Equity	0.72
Interest Coverage (TTM)	-
Debt Coverage (TTM)	0.53

Per Share	Current
Earnings (TTM)	1.24 $
Revenues (TTM)	15.62 $
Cash Flow (TTM)	-0.68 $
Cash	3.85 $
Book Value	12.23 $
Dividend (TTM)	1.92 $

MRK's Efficiency	Current
Revenue per Employee (TTM)	596,129
Net Income per Employee (TTM)	48,243
Receivable Turnover Ratio (TTM)	5.8
Inventory Turnover Ratio (TTM)	2.59
Asset Turnover Ratio (TTM)	0.49

MRK's Profitability Ratio	Current
Gross Margin	66.47 %
Operating Margin	23.1 %
Net Margin	18.14 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	57.66 %

Management Effectiveness	Current
Return On Assets (TTM)	3.93 %
Return On Investment (TTM)	5.12 %
Return On Equity (TTM)	10.09 %
Dividend Yield	2.57 %
Payout Ratio (TTM)	154.63 %

MRK's Valuation
Price to Earnings PE Ratio (TTM)	60.22
Price to Earnings PE Ratio (Expected)	46.30
Price to Sales (TTM)	4.79
Price to Sales (Expected)	5.12
Price to Book	6.12
PEG (TTM)	3.06

MRK's Financial Strength
Quick Ratio	0.55
Working Capital Ratio	1.44
Leverage Ratio (MRQ)	1.55
Total Debt to Equity	0.72
Interest Coverage (TTM)	-
Debt Coverage (TTM)	0.53

Per Share
Earnings (TTM)	1.24 $
Revenues (TTM)	15.62 $
Cash Flow (TTM)	-0.68 $
Cash	3.85 $
Book Value	12.23 $
Dividend (TTM)	1.92 $

• View Valuation Comparisons

• View Growth Rates Comparisons

MRK's Efficiency
Revenue per Employee (TTM)	596,129
Net Income per Employee (TTM)	48,243
Receivable Turnover Ratio (TTM)	5.8
Inventory Turnover Ratio (TTM)	2.59
Asset Turnover Ratio (TTM)	0.49

MRK's Profitability Ratio
Gross Margin	66.47 %
Operating Margin	23.1 %
Net Margin	18.14 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	57.66 %

Management Effectiveness
Return On Assets (TTM)	3.93 %
Return On Investment (TTM)	5.12 %
Return On Equity (TTM)	10.09 %
Dividend Yield	2.57 %
Payout Ratio (TTM)	154.63 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income grew by	MRK's customers Net margin grew to
19.12 %	4.03 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

You need to upgrade your Flash Player

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

PFE		0.02%
LLY		2.07%
JNJ		1.22%
CELG	-4.97%
BMY		1.77%
ABT	-0.62%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar WESC's Profile Stock Price WESC's Financials Business Description Fundamentals Charts & Quotes WESC's News Suppliers WESC's Competitors Customers & Markets Economic Indicators WESC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Expectations Management Effectivness	Glossary Financial Terms Technical Analysis Fundamental Analysis Energy Terms Manufacturing Terms Transportation Terms Health Care Insurance Terms Economy Terms Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

MRK Company Profile

Ideanomics, Inc announced third quarter operating loss of $-6.356557 millions

Apollo Medical Holdings, Inc announced third quarter operating profit of $56.577104 millions

Redemption of Losses but Revenues Unchanged

Rokk3r Inc announced third quarter operating deficit of $-0.945653 millions

Deficit Bigger Than a Year Ago, Sales Faded